Simplify Logo

Full-Time

Equipment Engineer

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Hardware
Biotechnology

Compensation Overview

$80k - $100kAnnually

Mid, Senior

Sacramento, CA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s degree in Engineering or Life Sciences, and prior work experience in a GMP manufacturing environment required
  • 4 years of experience in GMP manufacturing facility, including production equipment operation, troubleshooting and maintenance execution
Responsibilities
  • Analyze, troubleshoot, and resolve system/equipment performance, malfunctions, or failures
  • Track and report on equipment downtime, failure trends and develop corrective actions to prevent recurrence
  • Coordination of onsite and maintenance, calibration and certification activities completed by service providers
  • Execution of preventative and corrective maintenance tasks
  • Review and approval of service provider documentation
  • Completion and closeout of tasks in the CMMS
  • Ensure that production and laboratory assets are maintained, calibrated, and certified to applicable GMP standards
  • Develop and deliver training in support of asset operations, maintenance, and reliability
  • Collaboration with peers in the continuous improvement of production and laboratory equipment standards, practices, specifications, procedures, qualifications and business processes
  • Collaboration with site MSAT and Engineering on new equipment installations, technology development and existing equipment modifications
  • Lead and/or participate in the identification and development of solutions to stabilize and optimize equipment systems
  • Execution of small projects and continuous improvements
  • Other duties as assigned

Orca Bio operates in the biotechnology field, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to significantly impact healthcare by advancing cell therapy treatments for conditions that currently have limited options.

Company Stage

Series D

Total Funding

$375M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

8%

1 year growth

14%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.